Publications by authors named "E Van Cutsem"

Claim this Profile
T
Trastuzumab deruxtecan in HER2-positive stomach or gastroesophageal junction cancer: a plain language summary of the DESTINY-Gastric02 study.
Eric Van Cutsem

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma.
Luigi Brancato, Damar Osok, Laurent Van den Bossche, Eric Van Cutsem, Susan E Bates

Cancers (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-years of real-world data.
Pieter Maerten, Gilles Defraene, Albert Wolthuis, Cédric Schraepen, Gabriele Bislenghi, Eric Van Cutsem

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancers.
Mohamed E Salem, Alberto Puccini, Elizabeth Mauer, Thierry André, Thomas J George, Eric Van Cutsem

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial.
Halit Topal, Tom Venken, Ayse Bassez, Gabriela Chiritescu, Eric Van Cutsem

Commun Med (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis